Michael Cangkrama

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Signaling Pathway

Top Venues

EMBO molecular medicine

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Selina Gurri, Beat Siegenthaler, Michael Cangkrama, Gaetana Restivo, Marcel Huber, James Saliba, Reinhard Dummer, Volker Blank, Daniel Hohl, Sabine Werner
NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5. EMBO molecular medicine (2023)
Michael Cangkrama, Huan Liu, James Whipman, Maria Zubair, Mai Matsushita, Michela Di Filippo, Manfred Kopf, Metello Innocenti, Sabine Werner
A Protumorigenic mDia2-MIRO1 Axis Controls Mitochondrial Positioning and Function in Cancer-Associated Fibroblasts. Cancer research 82 (20) (2022)
Michael Cangkrama, Mateusz Wietecha, Nicolas Mathis, Rin Okumura, Luca Ferrarese, Dunja Al-Nuaimi, Maria Antsiferova, Reinhard Dummer, Metello Innocenti, Sabine Werner
A paracrine activin A-mDia2 axis promotes squamous carcinogenesis via fibroblast reprogramming. EMBO molecular medicine 12 (4) (2020)